The Shuman Law Firm Announces an Investigation on Behalf of QuadraMed Corp. Shareholders

The Shuman Law Firm today announced that it is investigating potential claims against the Board of Directors of QuadraMed Corp. (“QuadraMed” or the “Company”) (Nasdaq: QDHC) related to the proposed acquisition by Francisco Partners, a private equity firm. The deal is valued at approximately $126 million.

Under the terms of the transaction, Francisco Partners will acquire all outstanding shares of QuadraMed common stock for $8.50 per share and the Series A Cumulative Mandatory Convertible Preferred Stock for $13.7097 per share. The investigation concerns, in part, whether the board breached their fiduciary duties by not receiving fair value for the Company.

If you currently own the common stock of QuadraMed and would like a free consultation of your rights and interests with respect to this matter, please contact Kip B. Shuman or Rusty E. Glenn toll free at [phone] or email Mr. Shuman at [e-mail] or Mr. Glenn at [e-mail].

The Shuman Law Firm represents investors throughout the nation, concentrating its practice in securities class actions and shareholder derivative actions.